Real World Data

A Global Strategic Business Report

MCP35640

RESEARCH DASHBOARD

OCT 2025

RELEASE DATE

7148

EXECUTIVE POOL

5850

PRICE

817

EXPERT INPUTS

42

COMPANIES

108

DATA TABLES

180

PAGES

2

EDITION

WHAT'S BEHIND OUR DATA?

140857226

DOMAIN TRANSCRIPTS

6080276

BRANDS TRACKED

1729341

FEATURED COMPANIES

22574

TOPICS COVERED

82719

MARKET SEGMENTS

91

KEY INDUSTRIES

1574

CURATION TEAM

4761909

DECISION MAKERS

EXECUTIVE ENGAGEMENTS BY TIER (55)

3

CXO

5

VICE PRESIDENT

10

DIRECTOR

25

MANAGER

12

MARKETING

REQUEST FULL-STACK INDEX Includes 350+ pages validated sources

QUESTIONNAIRE EXECUTIVES DATA ROOM

OUR EXPERT PANELS

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

INFLUENCER INVITEE

WHY PARTICIPATE?

Expertise to the Power of YOU!

Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription

The Economist
MIT Technology Review
Harvard Business Review

Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.

MARKETGLASS

BASIC

Annual Prepaid Subscription
Single-User
10,000 Data Room Credits/Month
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use MarketGlass^TM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.

PREMIUM

Annual Prepaid Subscription
One Research Project With One Complimentary Update/Year
10-User License
10-User Peer-to-Peer Collaborative Features
200 Domain Expert Insights (With Name, Company, and Date)
50,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

ENTERPRISE

Annual Prepaid Subscription
Four Research Projects With One Complimentary Update/Year
25-User License
25-User Peer-to-Peer Collaborative Engagements
500 Domain Expert Insights (With Name, Company, and Date)
150,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

HIGHLIGHTS & REPORT INDEX

Global Real World Data Market to Reach US$5.4 Billion by 2030

The global market for Real World Data estimated at US$2.2 Billion in the year 2024, is expected to reach US$5.4 Billion by 2030, growing at a CAGR of 15.9% over the analysis period 2024-2030. Services, one of the segments analyzed in the report, is expected to record a 17.7% CAGR and reach US$3.7 Billion by the end of the analysis period. Growth in the Datasets segment is estimated at 12.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$590.5 Million While China is Forecast to Grow at 14.9% CAGR

The Real World Data market in the U.S. is estimated at US$590.5 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$835.4 Million by the year 2030 trailing a CAGR of 14.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 14.8% and 13.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.4% CAGR.

Global "Real World Data" Market – Key Trends & Drivers Summarized

Is Real World Data Reshaping The Future Of Evidence-Based Decision Making?
Real World Data (RWD) is becoming a cornerstone of healthcare innovation, shifting the paradigm from controlled clinical trials to evidence drawn from real-life patient experiences. Sourced from electronic health records (EHRs), insurance claims, patient registries, wearables, and mobile health apps, RWD provides insights into treatment efficacy, safety, adherence, and outcomes across diverse populations. It allows regulators, payers, and pharmaceutical companies to understand how therapies perform outside controlled environments, supporting adaptive clinical trials, pharmacovigilance, and value-based reimbursement models. In public health, RWD informs policy decisions and tracks disease progression in real-time. As healthcare systems push for personalized, data-driven care, RWD is emerging as a strategic asset that links patient behavior with actionable clinical insights.

What Technologies Are Unlocking The Full Potential Of RWD?
The explosion of health data and advances in data analytics are unlocking new frontiers for Real World Data utilization. Cloud computing, big data platforms, and AI algorithms are enabling the ingestion, harmonization, and real-time analysis of massive, heterogeneous datasets. Natural language processing (NLP) is extracting structured insights from clinical notes and unstructured EHR data. Interoperability frameworks like HL7 FHIR are improving data sharing across systems and stakeholders. Blockchain is being explored to ensure data provenance, security, and patient consent. These technologies are transforming RWD from passive records into dynamic resources that fuel drug development, population health strategies, and personalized treatment pathways. As data ecosystems mature, the quality, reliability, and regulatory acceptance of RWD are also improving.

How Are Stakeholders Across The Healthcare Ecosystem Embracing RWD?
Pharmaceutical companies are integrating RWD into all stages of the drug lifecycle—from trial design and site selection to post-market surveillance and label expansion. Regulators like the FDA and EMA are increasingly relying on RWD to support approvals and monitor safety in real-world populations. Payers are using RWD to assess cost-effectiveness and inform coverage decisions. Healthcare providers are applying RWD analytics to improve care coordination, reduce readmissions, and optimize treatment protocols. Patients are also becoming key stakeholders, contributing data through apps and wearable devices while demanding transparency and control. The convergence of stakeholder interests around RWD is fostering partnerships, data consortiums, and innovation hubs that accelerate the transformation of health data into health impact.

What’s Accelerating Growth In The Real World Data Market Globally?
The growth in the Real World Data market is driven by advancements in health data infrastructure, regulatory support, and end-user demand for personalized, value-based care. Technologically, improved analytics tools, cloud scalability, and interoperability standards are enabling actionable insights from vast and diverse datasets. From an end-use perspective, biopharma, payers, and health systems are leveraging RWD to drive efficiency, optimize outcomes, and meet evolving care expectations. Increased use of digital health tools, wearables, and patient engagement platforms is generating richer datasets for analysis. Regulatory initiatives supporting RWD in decision-making and policy formulation are also boosting market credibility. As global healthcare systems transition from volume to value, the ability to derive meaningful insights from real-world evidence is becoming a key competitive differentiator.

SCOPE OF STUDY

The report analyzes the Real World Data market by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Services, Datasets); Application (Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research, Other Applications); End-Use (Pharmaceutical & Medical Device Companies, Healthcare Payers, Healthcare Providers, Government Agencies, Other End-Uses).

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World..

SELECT PLAYERS

Aetion, Inc.; Atropos Health; BEKHealth; Cerner Corporation; Clarify Health Solutions; ConcertAI; Datavant; Evidera, Inc.; Flatiron Health, Inc.; HealthVerity; IBM Corporation; ICON plc; IQVIA Holdings Inc.; K2view; Merative; Mount Sinai Health System; Optum, Inc.; Palantir Technologies Inc.; PAREXEL International Corporation; SAS Institute Inc.

AI INTEGRATIONS

We’re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy

World Market Trajectories

How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind

Real World Data – Global Key Competitors Percentage Market Share in 2025 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for 42 Players Worldwide in 2025 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Accelerated Shift Toward Evidence-Based Healthcare Models Spurs Use of Real World Data

Increased Regulatory Acceptance of RWD in Drug Approvals and Label Expansions Drives Market Relevance

Rising Use of EHR, Claims, and Patient-Reported Outcomes Data Expands Data Variety

Growth in Value-Based Care and Health Economics Research Strengthens Demand for Real-World Evidence

AI and Advanced Analytics Integration Enhances Data Utility in Clinical and Commercial Strategy

Collaborations Between Pharma, Payers, and Tech Firms Propel RWD Platform Development

Decentralized Clinical Trials and Virtual Health Models Expand Demand for Real-Time Patient Data

Regulatory Pressure for Post-Market Surveillance and Pharmacovigilance Supports Adoption

Privacy Concerns and Data Governance Requirements Present Compliance Challenges

Global Expansion of Health Data Infrastructure Opens Regional Growth Opportunities

4. GLOBAL MARKET PERSPECTIVE

World Real World Data Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

World Recent Past, Current & Future Analysis for Real World Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Real World Data by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Datasets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Datasets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Healthcare Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Government Agencies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Government Agencies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Pharmaceutical & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Pharmaceutical & Medical Device Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Healthcare Payers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Healthcare Payers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Drug Development & Approvals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Drug Development & Approvals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Market Access & Reimbursement / Coverage Decisions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Market Access & Reimbursement / Coverage Decisions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Post-Market Surveillance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Post-Market Surveillance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Clinical Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES

Real World Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)

USA Recent Past, Current & Future Analysis for Real World Data by Component - Services and Datasets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA 6-Year Perspective for Real World Data by Component - Percentage Breakdown of Value Sales for Services and Datasets for the Years 2025 & 2030

USA Recent Past, Current & Future Analysis for Real World Data by End-Use - Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA 6-Year Perspective for Real World Data by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers for the Years 2025 & 2030

USA Recent Past, Current & Future Analysis for Real World Data by Application - Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA 6-Year Perspective for Real World Data by Application - Percentage Breakdown of Value Sales for Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications for the Years 2025 & 2030

CANADA

Canada Recent Past, Current & Future Analysis for Real World Data by Component - Services and Datasets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada 6-Year Perspective for Real World Data by Component - Percentage Breakdown of Value Sales for Services and Datasets for the Years 2025 & 2030

Canada Recent Past, Current & Future Analysis for Real World Data by End-Use - Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada 6-Year Perspective for Real World Data by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers for the Years 2025 & 2030

Canada Recent Past, Current & Future Analysis for Real World Data by Application - Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada 6-Year Perspective for Real World Data by Application - Percentage Breakdown of Value Sales for Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications for the Years 2025 & 2030

JAPAN

Real World Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)

Japan Recent Past, Current & Future Analysis for Real World Data by Component - Services and Datasets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan 6-Year Perspective for Real World Data by Component - Percentage Breakdown of Value Sales for Services and Datasets for the Years 2025 & 2030

Japan Recent Past, Current & Future Analysis for Real World Data by End-Use - Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan 6-Year Perspective for Real World Data by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers for the Years 2025 & 2030

Japan Recent Past, Current & Future Analysis for Real World Data by Application - Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan 6-Year Perspective for Real World Data by Application - Percentage Breakdown of Value Sales for Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications for the Years 2025 & 2030

CHINA

Real World Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)

China Recent Past, Current & Future Analysis for Real World Data by Component - Services and Datasets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China 6-Year Perspective for Real World Data by Component - Percentage Breakdown of Value Sales for Services and Datasets for the Years 2025 & 2030

China Recent Past, Current & Future Analysis for Real World Data by End-Use - Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China 6-Year Perspective for Real World Data by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers for the Years 2025 & 2030

China Recent Past, Current & Future Analysis for Real World Data by Application - Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China 6-Year Perspective for Real World Data by Application - Percentage Breakdown of Value Sales for Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications for the Years 2025 & 2030

EUROPE

Real World Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)

Europe Recent Past, Current & Future Analysis for Real World Data by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Real World Data by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030

Europe Recent Past, Current & Future Analysis for Real World Data by Component - Services and Datasets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Real World Data by Component - Percentage Breakdown of Value Sales for Services and Datasets for the Years 2025 & 2030

Europe Recent Past, Current & Future Analysis for Real World Data by End-Use - Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Real World Data by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers for the Years 2025 & 2030

Europe Recent Past, Current & Future Analysis for Real World Data by Application - Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Real World Data by Application - Percentage Breakdown of Value Sales for Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications for the Years 2025 & 2030

FRANCE

Real World Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)

France Recent Past, Current & Future Analysis for Real World Data by Component - Services and Datasets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France 6-Year Perspective for Real World Data by Component - Percentage Breakdown of Value Sales for Services and Datasets for the Years 2025 & 2030

France Recent Past, Current & Future Analysis for Real World Data by End-Use - Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France 6-Year Perspective for Real World Data by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers for the Years 2025 & 2030

France Recent Past, Current & Future Analysis for Real World Data by Application - Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France 6-Year Perspective for Real World Data by Application - Percentage Breakdown of Value Sales for Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications for the Years 2025 & 2030

GERMANY

Real World Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)

Germany Recent Past, Current & Future Analysis for Real World Data by Component - Services and Datasets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany 6-Year Perspective for Real World Data by Component - Percentage Breakdown of Value Sales for Services and Datasets for the Years 2025 & 2030

Germany Recent Past, Current & Future Analysis for Real World Data by End-Use - Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany 6-Year Perspective for Real World Data by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers for the Years 2025 & 2030

Germany Recent Past, Current & Future Analysis for Real World Data by Application - Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany 6-Year Perspective for Real World Data by Application - Percentage Breakdown of Value Sales for Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications for the Years 2025 & 2030

ITALY

Italy Recent Past, Current & Future Analysis for Real World Data by Component - Services and Datasets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy 6-Year Perspective for Real World Data by Component - Percentage Breakdown of Value Sales for Services and Datasets for the Years 2025 & 2030

Italy Recent Past, Current & Future Analysis for Real World Data by End-Use - Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy 6-Year Perspective for Real World Data by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers for the Years 2025 & 2030

Italy Recent Past, Current & Future Analysis for Real World Data by Application - Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy 6-Year Perspective for Real World Data by Application - Percentage Breakdown of Value Sales for Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications for the Years 2025 & 2030

UNITED KINGDOM

Real World Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)

UK Recent Past, Current & Future Analysis for Real World Data by Component - Services and Datasets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK 6-Year Perspective for Real World Data by Component - Percentage Breakdown of Value Sales for Services and Datasets for the Years 2025 & 2030

UK Recent Past, Current & Future Analysis for Real World Data by End-Use - Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK 6-Year Perspective for Real World Data by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers for the Years 2025 & 2030

UK Recent Past, Current & Future Analysis for Real World Data by Application - Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK 6-Year Perspective for Real World Data by Application - Percentage Breakdown of Value Sales for Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications for the Years 2025 & 2030

REST OF EUROPE

Rest of Europe Recent Past, Current & Future Analysis for Real World Data by Component - Services and Datasets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe 6-Year Perspective for Real World Data by Component - Percentage Breakdown of Value Sales for Services and Datasets for the Years 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Real World Data by End-Use - Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe 6-Year Perspective for Real World Data by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers for the Years 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Real World Data by Application - Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe 6-Year Perspective for Real World Data by Application - Percentage Breakdown of Value Sales for Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications for the Years 2025 & 2030

ASIA-PACIFIC

Real World Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)

Asia-Pacific Recent Past, Current & Future Analysis for Real World Data by Component - Services and Datasets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific 6-Year Perspective for Real World Data by Component - Percentage Breakdown of Value Sales for Services and Datasets for the Years 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Real World Data by End-Use - Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific 6-Year Perspective for Real World Data by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers for the Years 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Real World Data by Application - Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific 6-Year Perspective for Real World Data by Application - Percentage Breakdown of Value Sales for Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications for the Years 2025 & 2030

REST OF WORLD

Rest of World Recent Past, Current & Future Analysis for Real World Data by Component - Services and Datasets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of World 6-Year Perspective for Real World Data by Component - Percentage Breakdown of Value Sales for Services and Datasets for the Years 2025 & 2030

Rest of World Recent Past, Current & Future Analysis for Real World Data by End-Use - Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of World 6-Year Perspective for Real World Data by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Government Agencies, Other End-Uses, Pharmaceutical & Medical Device Companies and Healthcare Payers for the Years 2025 & 2030

Rest of World Recent Past, Current & Future Analysis for Real World Data by Application - Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of World 6-Year Perspective for Real World Data by Application - Percentage Breakdown of Value Sales for Drug Development & Approvals, Market Access & Reimbursement / Coverage Decisions, Post-Market Surveillance, Clinical Research and Other Applications for the Years 2025 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)	% VALIDATED RESEARCH *

* Login to Participate & View Data Stacks

* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlass^TM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.

View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.

Scroll